desert rock formation
justin reynods

Justin Reynolds, MD

Gastroenterology
Transplant Hepatology
Accepting New Patients

Justin Reynolds, MD, is a hepatologist and gastroenterologist in the Hereditary Hemorrhagic Telangiectasia (HHT) Program at Barrow Neurological Institute. He is board certified in transplant hepatology, gastroenterology, and internal medicine by the American Board of Internal Medicine.

Dr. Reynolds’ expertise is in diagnosing and treating diseases affecting the gastrointestinal tract, liver, pancreas, and gallbladder, especially vascular malformations caused by HHT. He is a member of the Alliance for Academic Internal Medicine, the American Association for the Study of Liver Diseases, the American College of Gastroenterology, the American Gastroenterological Association, the American Society of Transplantation, the European Association for the Study of the Liver, the International Liver Transplantation Society, and the Phoenix Society of Gastroenterology.

Dr. Reynolds earned his medical degree from the University of Michigan Medical School in Ann Arbor. He completed his internal medicine residency at Stanford University. He also completed a gastroenterology fellowship at the University of California at Los Angeles and a transplant hepatology fellowship at Mayo Clinic in Phoenix.

Dr. Reynolds’ research interests currently involve the treatment of people with nonalcoholic steatohepatitis (NASH), cirrhosis, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and liver transplant.

justin reynods

Justin Reynolds, MD

Gastroenterology
Transplant Hepatology
Accepting New Patients

Justin Reynolds, MD, is a hepatologist and gastroenterologist in the Hereditary Hemorrhagic Telangiectasia (HHT) Program at Barrow Neurological Institute. He is board certified in transplant hepatology, gastroenterology, and internal medicine by the American Board of Internal Medicine.

Dr. Reynolds’ expertise is in diagnosing and treating diseases affecting the gastrointestinal tract, liver, pancreas, and gallbladder, especially vascular malformations caused by HHT. He is a member of the Alliance for Academic Internal Medicine, the American Association for the Study of Liver Diseases, the American College of Gastroenterology, the American Gastroenterological Association, the American Society of Transplantation, the European Association for the Study of the Liver, the International Liver Transplantation Society, and the Phoenix Society of Gastroenterology.

Dr. Reynolds earned his medical degree from the University of Michigan Medical School in Ann Arbor. He completed his internal medicine residency at Stanford University. He also completed a gastroenterology fellowship at the University of California at Los Angeles and a transplant hepatology fellowship at Mayo Clinic in Phoenix.

Dr. Reynolds’ research interests currently involve the treatment of people with nonalcoholic steatohepatitis (NASH), cirrhosis, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and liver transplant.